Sharma, V.; Bagrodia, V.; Kulshreshtra, A. Enhancing Hemophilia A Management: Emicizumab As a Cost-Effective Adjunct to Standard Therapy for Inhibitor Patients. Int J Basic Clin Pharmacol 2024, 13, 395-397.